Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Speech-in-Noise Treatments for Hypophonia in Parkinson's Disease [Phase 2]
A Phase 2 clinical trial update exploring speech-in-noise treatments for hypophonia in Parkinson's disease.
-
FDA approval · 2020-03-25FDA Approved: DATSCAN — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)
The FDA approved a supplemental application for DATSCAN (IOFLUPANE I-123) submitted by Medi-Physics Inc. dba GE Healthcare. This action upda…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia [Phase 2]
Phase 2 trial update on IRL790 for Parkinson's disease dyskinesia reports efficacy and tolerability results.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Scalar Closed Loop Intraoperative Study [NA]
A completed clinical trial update for the Scalar Closed Loop Intraoperative study in Parkinson disease with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment [Phase 4]
Phase 4 clinical trial investigating quantitative methods to guide rational treatment for anxiety in Parkinson disease; study terminated wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients [Phase 2]
Phase 2 trial evaluating foliglurax (PXT002331) for reducing motor complications from levodopa in Parkinson disease completed.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial [Phase 3]
A continuation treatment protocol update for a participant in the Phase 3 BIA 9-1067-302 clinical trial.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Kinematic-based BoNT-A Bilateral Upper Limb PD Therapy [Phase 2]
A Phase 2 clinical trial evaluating kinematic-based botulinum toxin type A therapy for bilateral upper limb symptoms in Parkinson's disease …
-
FDA approval · 2020-03-10FDA Approved: GOCOVRI — Supplemental Application (Adamas Pharma, LLC)
FDA approves a supplemental application for GOCOVRI (amantadine) submitted by Adamas Pharma, LLC.
-
FDA approval · 2020-03-10FDA Approved: AMANTADINE HYDROCHLORIDE — Original Application (Marlex Pharmaceuticals Inc)
FDA approved amantadine hydrochloride as an original ANDA for a generic version. The product is manufactured by Marlex Pharmaceuticals Inc.
-
FDA approval · 2020-03-03FDA Approved: SINEMET — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Sinemet (carbidopa and levodopa) from Organon LLC.
-
FDA approval · 2020-03-02FDA Approved: AMANTADINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved Rising Pharma's generic amantadine hydrochloride (oral) under an Original Application (ANDA 210129), authorizing its market…
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO [Phase 2]
A Phase 2 randomized trial evaluating an innovative custom ankle-foot orthosis (AFO) for efficacy, acceptability, and perceived benefit in i…
-
FDA approval · 2020-02-21FDA Approved: ROPINIROLE HYDROCHLORIDE — Supplemental Application (SOLCO HEALTHCARE US, LLC)
FDA approved a supplemental application for ropinirole hydrochloride (Solco Healthcare US, LLC), enabling the marketing of the generic produ…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Study to Characterize Acute and Chronic Directional Aspects of Deep Brain Stimulation [NA]
Completed clinical trial investigating acute and chronic directional aspects of deep brain stimulation in Parkinson disease; results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease? [NA]
Completed clinical trial evaluating outpatient palliative care for Parkinson's disease with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Norepinephrine-targeted Therapy for Action Control in Parkinson Disease [Phase 4]
Phase 4 trial updating norepinephrine-targeted therapy for action control in Parkinson disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Multi-chip Meta-analysis of Parkinson's Disease for Clinical Validation of Small Samples of Key Genes in Disease
A completed clinical trial studying multi-chip meta-analysis of Parkinson's disease for validation of key genes using small samples.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Efficacy of Isradipine in Early Parkinson Disease [Phase 3]
Phase 3 trial assessing efficacy of isradipine in early Parkinson disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the safety of CDNF delivered by brain infusion in patients with Parkinson's disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: High and Low Dose Carbidopa Treatment of Parkinson's Disease [Phase 2]
A Phase 2 clinical trial evaluating high and low dose carbidopa treatment in Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness [Phase 2]
Phase 2 trial update on JZP-110 for Parkinson's disease with excessive daytime sleepiness assessing safety, efficacy, and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel
Clinical trial update on mono- and combination therapy with levodopa-carbidopa intestinal gel for Parkinson's disease; study completed with …
-
FDA approval · 2020-01-02FDA Approved: RASAGILINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Rasagiline submitted by Ascend Laboratories, LLC. This action updates the Rasagiline product…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Buspirone in Parkinson's Disease [Phase 2]
Phase 2 clinical trial update for buspirone in Parkinson's disease and anxiety has completed with posted results.